Dendritic Cell

Safety, feasibility and functionality of activated autologous dendritic cells for intratumoral injection in solid tumors: a Phase I clinical trial
Vivek Subbiah, Ravi Murthy, David Hong, Robert Prins, Chitra Hosing, Robert Brown, McGuire Mary, Aung Naing, Siquing Fu, Anthony Conley, Indreshpaul Kaur, Kyle Hendricks, Deepthi Kolli, Lori Noffsinger, Marnix Bosch

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P199; DOI: 10.1186/2051-1426-3-S2-P199
Functional antigen presenting cells generated from human dendritic cells (DC) derived induced pluripotent stem cell lines
Arvind Chhabra

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P206; DOI: 10.1186/2051-1426-3-S2-P206
Efficient isolation of monocytes from PBMCs utilizing a newly developed material
Xue Zhang, Takayuki Miyamoto, Yoshiko Miura

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P212; DOI: 10.1186/2051-1426-3-S2-P212
Selective costimulation by IL-15R/IL-15, but not IL-2R/IL-2, allows the induction of high numbers of tumor-specific CD8+ T cells by human dendritic cells matured in conditions of acute inflammation
Morten Hansen, Eva Wieckowski, Inge Marie Svane, Robert P Edwards, Pawel Kalinski

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P223; DOI: 10.1186/2051-1426-3-S2-P223
Mass-production of human dendritic cells in accordance with gmp for clinical studies
Yui Harada, Noriko Yasuda, Yoshikazu Yonemitsu

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P207; DOI: 10.1186/2051-1426-3-S2-P207
Counteracting breast-cancer induced immune suppression by reactivating lymph node-resident conventional dendritic cells (LNR-cDC)
Rieneke van de Ven, Kim van Pul, Shaghayegh Aliabadi, Petrousjka van den Tol, Lisette A te Velde, Emiel JTh Rutgers, Ronald JCLM Vuylsteke, Hein BAC Stockmann, Christopher Dubay, Chris Harrington, Bernard A Fox, Tanja D de Gruijl

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P276; DOI: 10.1186/2051-1426-3-S2-P276
Induction of systemic and therapeutic antitumor immunity using intratumoral injection of bone-marrow derived dendritic cells genetically modified to express interleukin 12 combined with anti-CTLA-4 antibody
Marimo Sato-Matsushita, Yoshihiro Hayakawa, Asuka Asami, Setsuko Nakayama, Hideaki Tahara

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P243; DOI: 10.1186/2051-1426-3-S2-P243
Evaluation of the immunogenicity of aldhhigh human head and neck squamous cell carcinoma cancer stem cells in vitro
Qiao Li, Mark Prince

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P28; DOI: 10.1186/2051-1426-3-S2-P28
Local administration of granulocyte macrophage colony-stimulating factor induces local accumulation of dendritic cells and antigen-specific CD8+ T cells and enhances the efficacy of therapeutic vaccine in cervicovaginal tumor
Sung-Jong Lee, TC Wu, Chien-Fu Hung

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P365; DOI: 10.1186/2051-1426-3-S2-P365
Core skin DC signatures control immune tolerance to skin cancer and limit anti-tumor immunity
Christopher Nirschl, Yong Liu, Kavita Sarin, Mayte Suarez-Farinas, David Chau, Peter Sage, Arlene Sharpe, Niroshana Anandasabapathy

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P205; DOI: 10.1186/2051-1426-3-S2-P205

Main menu

Dendritic Cell

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Dendritic Cell

Pages